Developer of Tumor Immune Cell Therapy Technologies and Products

Medical Device Manufacturing Enterprise
China Securities News (reported by Wang Lizhi) - According to the WeChat Official Account "Pudong Release" on March 7, the conference "Serving the New Development Paradigm and Promoting High-Quality Development: Pudong New Area Foreign-Funded R&D Centers Promotion Conference" was recently held. The first batch of seven foreign-funded R&D centers that obtained the qualification for tax-free import of scientific and technological innovation were awarded plaques. These seven foreign-funded R&D centers are Dow Chemical (China) Investment Company Limited, GENERAL MOTORS (China) Investment Company Limited, Fosun Kite Biotechnology Co., Ltd., Beken Corporation, Thyssen Krupp Presta Shanghai Co., Ltd., Mercure Technology (Shanghai) Co., Ltd., and SIEMENS Healthineers.